HAVCR1 and acute kidney injury: This study aims to establish a highly sensitive time‐resolved fluorescence immunoassay (TRFIA) to detect the serum Kim‐1 concentration of healthy controls and patients with AKI to provide a reference for the clinical diagnosis and treatment of patients with AKI.